These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11897658)

  • 1. Reprogrammed gene expression in a somatic cell-free extract.
    Landsverk HB; Håkelien AM; Küntziger T; Robl JM; Skålhegg BS; Collas P
    EMBO Rep; 2002 Apr; 3(4):384-9. PubMed ID: 11897658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclic adenosine 5'-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism.
    Tenbrock K; Juang YT; Tolnay M; Tsokos GC
    J Immunol; 2003 Mar; 170(6):2971-6. PubMed ID: 12626549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T cell activation.
    Attema JL; Reeves R; Murray V; Levichkin I; Temple MD; Tremethick DJ; Shannon MF
    J Immunol; 2002 Sep; 169(5):2466-76. PubMed ID: 12193716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming fibroblasts to express T-cell functions using cell extracts.
    Håkelien AM; Landsverk HB; Robl JM; Skålhegg BS; Collas P
    Nat Biotechnol; 2002 May; 20(5):460-6. PubMed ID: 11981558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells.
    Siebenlist U; Durand DB; Bressler P; Holbrook NJ; Norris CA; Kamoun M; Kant JA; Crabtree GR
    Mol Cell Biol; 1986 Sep; 6(9):3042-9. PubMed ID: 3491296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential activation of nuclear factor of activated T cells c correlates with mouse strain susceptibility to allergic responses and interleukin-4 gene expression.
    Keen JC; Sholl L; Wills-Karp M; Georas SN
    Am J Respir Cell Mol Biol; 2001 Jan; 24(1):58-65. PubMed ID: 11152651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylation inhibits IL4 gene expression in T cells.
    Valapour M; Guo J; Schroeder JT; Keen J; Cianferoni A; Casolaro V; Georas SN
    J Allergy Clin Immunol; 2002 Feb; 109(2):238-45. PubMed ID: 11842291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell specific enhancement of histone H3 acetylation in 5' flanking region of the IL-2 gene.
    Wang L; Kametani Y; Katano I; Habu S
    Biochem Biophys Res Commun; 2005 Jun; 331(2):589-94. PubMed ID: 15850801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic binding of Ku80, Ku70 and NF90 to the IL-2 promoter in vivo in activated T-cells.
    Shi L; Qiu D; Zhao G; Corthesy B; Lees-Miller S; Reeves WH; Kao PN
    Nucleic Acids Res; 2007; 35(7):2302-10. PubMed ID: 17389650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.
    Briegel K; Hentsch B; Pfeuffer I; Serfling E
    Nucleic Acids Res; 1991 Nov; 19(21):5929-36. PubMed ID: 1945879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium/calmodulin-dependent protein kinase II downregulates both calcineurin and protein kinase C-mediated pathways for cytokine gene transcription in human T cells.
    Hama N; Paliogianni F; Fessler BJ; Boumpas DT
    J Exp Med; 1995 Mar; 181(3):1217-22. PubMed ID: 7869038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive and negative regulation of IL-2 gene expression: role of multiple regulatory sites.
    Zhang L; Nabel GJ
    Cytokine; 1994 May; 6(3):221-8. PubMed ID: 8054477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear reprogramming in cell-free extracts.
    Collas P
    Philos Trans R Soc Lond B Biol Sci; 2003 Aug; 358(1436):1389-95. PubMed ID: 14511486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of IL-2Ralpha gene expression: structural changes within the proximal enhancer/core promoter during T-cell development.
    Yeh JH; Spicuglia S; Kumar S; Sanchez-Sevilla A; Ferrier P; Imbert J
    Nucleic Acids Res; 2002 May; 30(9):1944-51. PubMed ID: 11972331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions.
    Ward SB; Hernandez-Hoyos G; Chen F; Waterman M; Reeves R; Rothenberg EV
    Nucleic Acids Res; 1998 Jun; 26(12):2923-34. PubMed ID: 9611237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted histone acetylation and altered nuclease accessibility over short regions of the pea plastocyanin gene.
    Chua YL; Brown AP; Gray JC
    Plant Cell; 2001 Mar; 13(3):599-612. PubMed ID: 11251099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression.
    Qiu P; Li L
    Circ Res; 2002 May; 90(8):858-65. PubMed ID: 11988486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
    Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
    J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional control of IL-2 and IL-4 in T cells of young and old mice.
    Albright JW; Zúñiga-Pflücker JC; Albright JF
    Cell Immunol; 1995 Sep; 164(2):170-5. PubMed ID: 7656324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel T-cell trans-activator that recognizes a phorbol ester-inducible element of the interleukin-2 promoter.
    Radler-Pohl A; Pfeuffer I; Karin M; Serfling E
    New Biol; 1990 Jun; 2(6):566-73. PubMed ID: 2088505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.